United States · FDA National Drug Code directory
LORATADINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59556-917_0df1189a-9973-e8b7-e063-6294a90a61a3
- Product NDC
- 59556-917
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- LORATADINE
- Labeler
- Strides Pharma Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210810
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (59556-917-01) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59556-917-01
- 2 BLISTER PACK in 1 CARTON (59556-917-02) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59556-917-02
- 3 BLISTER PACK in 1 CARTON (59556-917-03) / 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59556-917-03
- 4 BLISTER PACK in 1 CARTON (59556-917-04) / 40 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59556-917-04
- 5 BLISTER PACK in 1 CARTON (59556-917-05) / 50 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59556-917-05
- 6 BLISTER PACK in 1 CARTON (59556-917-06) / 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59556-917-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →